
Alnylam-discovered cemdisiran, an siRNA silencing complement C5, is the first RNAi therapy approved for AChR-positive generalized myasthenia gravis.
Innovative qPCR tools for your bioanalysis and quality control. Fast-track your bioanalysis & QC with scalable innovative qPCR tools.







